2-(Arylamino)aryliminophosphoranes from 2-nitrodiarylamines
作者:Emilia Łukasik、Zbigniew Wróbel
DOI:10.1002/hc.21348
日期:2016.11
presented as an efficient method for synthesis of 2-(arylamino)aryliminophosphoranes, useful as starting materials in the synthesis of benzannulated nitrogen heterocycles. The reaction is complementary for the known synthesis of aryliminophosphoranes from2-nitrosodiarylamines giving rise to obtain the title products in the broader scope. The presented protocol is simple and efficient although limited to
Simple Synthesis of N-Aryl-2-nitrosoanilines in the Reaction of Nitroarenes with Aniline Anion Derivatives
作者:Zbigniew Wróbel、Andrzej Kwast
DOI:10.1055/s-0030-1258230
日期:2010.11
Anions generated from primary arylamines react with substituted nitrobenzenes to form ÏH-adducts, which, under basic reaction conditions, undergo transformation to N-aryl-2-nitrosoamines. Competitive substitution of reactive halogens in the nitroarenes, which is observed in certain cases, can be controlled by the solvent selected.
Control of parasites in animals by N-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and N-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives
申请人:Meyer Gerhard Adam
公开号:US20060281695A1
公开(公告)日:2006-12-14
Methods for treating an animal for endo and/or ecto parasite infestation and/or for protecting an animal from endo and/or ecto parasite infestation using N-phenyl-1,1,1-trifluoromethanesulfonamide compounds are provided, together with methods of making the same compounds, and methods of using the same compounds to treat parasite infestations in vivo or ex vivo. N-phenyl-1,1,1-trifluoromethanesulfonamides are also provided.
The present invention relates to a GPR40 receptor function regulator comprising a fused imidazole compound represented by the formula:
wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof. The GPR40 receptor function regulator is useful as an agent for the prophylaxis or treatment of obesity, hyperinsulinemia, type 2 diabetes and the like.